Skip to main content

Zumutor Biologics

Woburn, United States

Zumutor Biologics develops immuno-oncology therapies that harness the body's innate immune system to treat cancer.

$7.3M raised
Jun 2026
Series B

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Zumutor Biologics

How much funding has Zumutor Biologics raised?
Zumutor Biologics has raised $7.3M in total funding. The most recent round was Series B. The last funding was announced in June 2026.
Who are Zumutor Biologics's investors?
Zumutor Biologics's investors include Raj Dandu, Accel, Chiratae Ventures, Bharat Innovation Fund, Ashish Kacholia.
Where is Zumutor Biologics headquartered?
Zumutor Biologics is headquartered in Woburn, United States.
What does Zumutor Biologics do?
Zumutor Biologics develops immuno-oncology therapies that harness the body's innate immune system to treat cancer.
What stage is Zumutor Biologics at?
Zumutor Biologics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Zumutor Biologics — Funding & Investors." VCBacked, June 13, 2026, https://www.vcbacked.co/company/zumutor-biologics. Accessed July 2, 2026.
APA
VCBacked. (2026). Zumutor Biologics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/zumutor-biologics
Wikipedia (cite web)
{{cite web |title=Zumutor Biologics — Funding & Investors |url=https://www.vcbacked.co/company/zumutor-biologics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .